Innovate.AI is a global competition launched by M12 to recognise and award capital to high-potential AI and machine learning start-ups
Providing a living nerve-growth guide that mimics nerve structure with the potential to enable both neural regeneration and functional recovery
Grapeshot provides brand safety and pre-bid contextual solutions to over 5,000 of the world’s leading marketers
PAUG enables gym users to access a national network of thousands of health and fitness clubs, pools, classes and spas, on a flexible pay-as-you-go, short-term pass or unlimited membership basis
This acquisition strengthens Orchard’s position as a global leader in gene therapy for rare diseases. GSK will continue to invest in the development of its platform capabilities in cell and gene therapies, with a focus on oncology.
Twenty-two leading financial services companies have so far pledged their commitment to help create a culture of social impact investing in the UK
MediaGamma has developed a world leading enterprise-grade reinforcement machine learning (self-learning) platform, delivering decisions in under five milliseconds
This unique collaboration combines the deep technology and clinical expertise of Optellum with the software platforms and rapid development know-how of Mirada